|
1
|
Saleem AF, Qamar FN, Shahzad H, Qadir M
and Zaidi AK: Trends in antibiotic susceptibility and incidence of
late-onset Klebsiella pneumoniae neonatal sepsis over a six-year
period in a neonatal intensive care unit in Karachi, Pakistan. Int
J Infect Dis. 17:e961–e965. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwaber MJ, Lev B, Israeli A, Solter E,
Smollan G, Rubinovitch B, Shalit I and Carmeli Y: Israel
Carbapenem-Resistant Enterobacteriaceae Working Group: Containment
of a country-wide outbreak of carbapenem-resistant Klebsiella
pneumoniae in Israeli hospitals via a nationally implemented
intervention. Clin Infect Dis. 52:848–855. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nicolau DP: Carbapenems: A potent class of
antibiotics. Expert Opin Pharmacother. 9:23–37. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ulu AC, Kurtaran B, Inal AS, Kömür S,
Kibar F, Çiçekdemir HY, Bozkurt S, Gürel D, Kılıç F, Yaman A, et
al: Risk factors of carbapenem-resistant Klebsiella pneumoniae
infection: A serious threat in ICUs. Med Sci Monit. 21:219–224.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kontopidou F, Giamarellou H, Katerelos P,
Maragos A, Kioumis I, Trikka-Graphakos E, Valakis C and Maltezou
HC: Group for the Study of KPC-producing Klebsiella pneumoniae
infections in intensive care units: Infections caused by
carbapenem-resistant Klebsiella pneumoniae among patients in
intensive care units in Greece: A multi-centre study on clinical
outcome and therapeutic options. Clin Microbiol Infect.
20:O117–O123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Diene SM and Rolain JM: Carbapenemase
genes and genetic platforms in Gram-negative bacilli:
Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin
Microbiol Infect. 20:831–838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Steinmann J, Kaase M, Gatermann S, Popp W,
Steinmann E, Damman M, Paul A, Saner F, Buer J and Rath P: Outbreak
due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in
a German university hospital, July 2010 to January 2011. Euro
Surveill. 16:199442011.PubMed/NCBI
|
|
8
|
Ho PL, Lo WU, Yeung MK, Lin CH, Chow KH,
Ang I, Tong AH, Bao JY, Lok S and Lo JY: Complete sequencing of
pNDM-HK encoding NDM-1carbapenemase from a multidrug-resistant
Escherichia coli strain isolated in Hong Kong. PLoS One.
6:e179892011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu F, Chen S, Xu X, Guo Y, Liu Y, Zhu D
and Zhang Y: Emergence of carbapenem-resistant clinical
Enterobacteriaceae isolates from a teaching hospital in Shanghai,
China. J Med Microbiol. 61:132–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Wang Y, Tian L, Zhu X, Li L, Zhang
B, Yan S and Sun Z: First Report in China of enterobacteriaceae
clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance
genes. Microb Drug Resist. 21:167–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin Y, Shao C, Li J, Fan H, Bai Y and Wang
Y: Outbreak of Multidrug Resistant NDM-1-Producing Klebsiella
pneumoniae from a neonatal unit in Shandong Province, China. PLoS
One. 10:e01195712015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clinical and Laboratory Standards
Institute, . Method for dilution antimicrobial susceptibility tests
for bacteria that grow aerobically. approved standard-ninth
edition, 2012, M07-A9. Wayne, PA: CLSI; 2012
|
|
13
|
Clinical and Laboratory Standards
Institute, . Performance standards for antimicrobial susceptibility
testing twentieth informational supplement. 2014, M100-S24. Wayne,
PA: CLSI; 2014
|
|
14
|
Lee K, Chong Y, Sllin HB, Kim YA, Yong D
and Yum JH: Modified Hodge and EDTA disk synergy tests to screen
metallo-beta-lactamase producing strains of Pseudomonas and
Acinetobacter species. Clin Microbiol Infect. 7:88–91. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Queenan AM and Bush K: Carbapenemases: The
versatile beta-lactamases. Clin Microbiol Rev. 20:440–458. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang H, Ataker F, Hedin G and Dornbusch K:
Molecular epidermiology of extended-spectrum beta-lactamases among
Escherichia coli isolates collected in a Swedish hospital and its
associated health care facilities from 2001 to 2006. J Clin
Microbio. 46:707–712. 2008. View Article : Google Scholar
|
|
17
|
Pérez-Pérez FJ and Hanson ND: Detection of
plasmid-mediated AmpC beta-lactamase genes in clinical isolates by
using multiplex PCR. J Clin Microbio. 40:2153–2162. 2002.
View Article : Google Scholar
|
|
18
|
Robicsek A, Strahilevitz J, Sahm DF,
Jacoby GA and Hooper DC: qnr prevalence in ceftazidime-resistant
enterobacteriaceae isolates from the United States. Antimicrob
Agents Chemother. 50:2872–2874. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tenover FC, Arbeit RD, Goering RV,
Mickelsen PA, Murray BE, Persing DH and Swaminathan B: Interpreting
chromosomal DNA restriction patterns produced by pulsed-field gel
electrophoresis: Criteria for bacterial strain typing. J Clin
Microbiol. 33:2233–2239. 1995.PubMed/NCBI
|
|
20
|
Doumith M, Ellington MJ, Livennore DM and
Woodford N: Molecular mechanisms disrupting porin expression in
ertapenem-resistant Klebsiella and Enterobacter spp. clinical
isolates from the UK. J Antimicrob Chemother. 63:659–667. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hernández-Allés S, Albertí S, Alvarez D,
Doménech-Sánchez A, Martínez-Martínez L, Gil J, Tomás JM and Benedí
VJ: Porin expression in clinical isolates of Klebsiella pneumoniae.
Microbiology. 145:673–679. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paterson DL: Recommendation for treatment
of severe infection caused by Enterobacteriaceae producing
extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect.
6:460–463. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ghotaslou R, Ghorashi Z and Nahaei MR:
Klebsiella pneumoniae in neonatal sepsis: A 3-year-study in the
pediatric hospital of Tabriz, Iran. Jpn J Infect Dis. 60:126–128.
2007.PubMed/NCBI
|
|
24
|
Borer A, Saidel-Odes L, Riesenberg K,
Eskira S, Peled N, Nativ R, Schlaeffer F and Sherf M: Attributable
mortality rate for carbapenem-resistant Klebsiella pneumoniae
bacteremia. Infect Control Hosp Epidemiol. 30:972–976. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cherkaoui A, Emonet S, Renzi G, Riat A,
Greub G and Schrenzel J: ESBL and carbapenemases in
Enterobacteriaceae. Rev Med Suisse. 10:2142–2148. 2014.(In French).
PubMed/NCBI
|
|
26
|
Stock I: Infectious diseases caused by
carbapenemase-producing Enterobacteriaceae - a particular challenge
for antibacterial therapy. Med Monatsschr Pharm. 37:162–172; quiz
173–174. 2014.[(In German)]. PubMed/NCBI
|
|
27
|
Peirano G, Sang JH, Pitondo-Silva A,
Laupland KB and Pitout JD: Molecular epidemiology of
extended-spectrum-β-lactamase-producing Klebsiella pneumoniae over
a 10 year period in Calgary, Canada. J Antimicrob Chemother.
67:1114–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mavroidi A, Liakopoulos A, Gounaris A,
Goudesidou M, Gaitana K, Miriagou V and Petinaki E: Successful
control of a neonatal outbreak caused mainly by ST20
multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece.
BMC Pediatr. 14:1052014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Delgado-Valverde M, Sojo-Dorado J, Pascual
A and Rodríguez-Baño J: Clinical management of infections caused by
multidrug-resistant Enterobacteriaceae. Ther Adv Infect Dis.
1:49–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doménech-Sánchez A, Hernández-Allés S,
Martínez-Martínez L, Benedí VJ and Albertí S: Identification and
characterization of a new porin gene of Klebsiella pneumoniae: Its
role in beta-lactam antibiotic resistance. J Bacteriol.
181:2726–2732. 1999.PubMed/NCBI
|
